Old Web
English
Sign In
Acemap
>
authorDetail
>
Moshe Talpaz
Moshe Talpaz
University of Texas MD Anderson Cancer Center
Immunology
Medicine
Chronic myelogenous leukemia
Chemotherapy
Alpha interferon
4
Papers
292
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1 study of polyethylene glycol formulation of interferon α-2B (Schering 54031) in Philadelphia chromosome–positive chronic myelogenous leukemia
2001
Blood
Moshe Talpaz
Susan O'Brien
Esther Rose
Samir Gupta
Jianqin Shan
Jorge E. Cortes
Francis J. Giles
Stefan Faderl
Hagop M. Kantarjian
Show All
Source
Cite
Save
Citations (65)
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional- dose chemotherapy before collection of autologous cells
1995
Blood
Moshe Talpaz
Hagop M. Kantarjian
Jan C. Liang
Leslie Calvert
J Hamer
P Tibbits
A. Durett
David F. Claxton
Sergio Giralt
Issa F Khouri
Show All
Source
Cite
Save
Citations (37)
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia
1991
Cancer
Paul J. Schilling
Razelle Kurzrock
Hagop M. Kantarjian
Jordan U. Gutterman
Moshe Talpaz
Show All
Source
Cite
Save
Citations (121)
Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor
1990
Blood
Eli Estey
D. O. Dixon
Hagop M. Kantarjian
Michael J. Keating
Kenneth B. McCredie
Gerald P. Bodey
Razelle Kurzrock
Moshe Talpaz
Emil J. Freireich
Albert B. Deisseroth
Show All
Source
Cite
Save
Citations (69)
1